Fulgent Genetics (FLGT) Long-Term Investments (2017 - 2026)

Fulgent Genetics (FLGT) has 10 years of Long-Term Investments data on file, last reported at $328.3 million in Q1 2026.

• Quarterly Long-Term Investments fell 33.56% year-over-year to $328.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $328.3 million (down 33.56% YoY) and the FY2025 annual result came in at $369.3 million, down 35.26% from the prior year.
• Long-Term Investments slipped to $328.3 million in Q1 2026 per FLGT's latest filing, from $369.3 million in the prior quarter.
• The five-year high for Long-Term Investments was $602.2 million in Q3 2024, with the low at $326.6 million in Q4 2022.
• Average Long-Term Investments over 5 years is $439.5 million, with a median of $415.6 million recorded in 2022.
• Year-over-year, Long-Term Investments surged 71.47% in 2022 and tumbled 35.26% in 2025.
• Fulgent Genetics' Long-Term Investments stood at $326.6 million in 2022, then grew by 29.67% to $423.6 million in 2023, then surged by 34.65% to $570.4 million in 2024, then plunged by 35.26% to $369.3 million in 2025, then declined by 11.1% to $328.3 million in 2026.
• Business Quant data shows FLGT's Long-Term Investments at $328.3 million in Q1 2026, $369.3 million in Q4 2025, and $411.8 million in Q3 2025.